Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRS Amyris, Inc. daily Stock Chart
AMRS [NASD]
Amyris, Inc.
Index- P/E- EPS (ttm)-0.42 Insider Own0.80% Shs Outstand257.98M Perf Week-5.59%
Market Cap199.73M Forward P/E- EPS next Y-0.19 Insider Trans-80.52% Shs Float175.50M Perf Month-4.42%
Income-90.50M PEG- EPS next Q-0.04 Inst Own36.30% Short Float3.28% Perf Quarter80.05%
Sales54.80M P/S3.64 EPS this Y85.00% Inst Trans-0.49% Short Ratio1.22 Perf Half Y48.88%
Book/sh-0.65 P/B- EPS next Y24.00% ROA-87.50% Target Price2.15 Perf Year-49.73%
Cash/sh0.01 P/C86.84 EPS next 5Y30.00% ROE57.30% 52W Range0.31 - 1.81 Perf YTD-52.21%
Dividend- P/FCF- EPS past 5Y27.10% ROI2780.40% 52W High-57.23% Beta0.40
Dividend %- Quick Ratio0.10 Sales past 5Y-15.70% Gross Margin17.40% 52W Low149.74% ATR0.07
Employees418 Current Ratio0.20 Sales Q/Q208.10% Oper. Margin- RSI (14)46.88 Volatility6.50% 7.61%
OptionableYes Debt/Eq- EPS Q/Q85.50% Profit Margin- Rel Volume0.47 Prev Close0.81
ShortableYes LT Debt/Eq- EarningsNov 02 AMC Payout- Avg Volume4.72M Price0.77
Recom2.00 SMA20-5.11% SMA50-6.45% SMA2006.30% Volume2,217,740 Change-4.06%
May-28-14Resumed Stifel Hold
Feb-10-12Downgrade Deutsche Bank Buy → Hold $20 → $9
Nov-02-11Downgrade Robert W. Baird Outperform → Neutral $25 → $16
Jan-28-11Downgrade Stifel Nicolaus Buy → Hold
Nov-08-10Initiated Stifel Nicolaus Buy $22
Dec-06-16 08:30AM  Amyris Partners with Queensland to Create the leading Industrial Biotechnology Hub in Southeast Asia GlobeNewswire
Dec-05-16 08:17AM  Here's Why Amyris Stock Dropped 16.8% in November at Motley Fool
Dec-02-16 04:43PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
Dec-01-16 08:30AM  Amyris Signs Multi-Year Collaboration Extension with Kuraray GlobeNewswire -6.82%
Nov-29-16 08:40AM  Weakness Seen in Amyris (AMRS) Estimates: Should You Stay Away? -6.25%
Nov-22-16 08:30AM  Amyris to Present at Four Upcoming Investor Conferences in December GlobeNewswire
Nov-18-16 05:14PM  AMYRIS, INC. Files SEC form 8-K, Other Events
12:56PM  ETFs with exposure to Amyris, Inc. : November 18, 2016
Nov-17-16 01:04PM  AMYRIS, INC. Financials
Nov-16-16 05:17PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
08:30AM  Amyris Achieves Key Milestone in Major Drug Discovery Collaboration GlobeNewswire
Nov-09-16 03:43PM  AMYRIS, INC. Files SEC form 10-Q, Quarterly Report
Nov-07-16 12:03PM  ETFs with exposure to Amyris, Inc. : November 7, 2016
Nov-04-16 04:34PM  AMYRIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
11:43AM  Amyris, Inc. :AMRS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016
Nov-03-16 04:24PM  Why Amyris, Inc. Stock Plunged 24% at Motley Fool -25.24%
03:55PM  Arzeda Scales High-throughput, Automated Molecule Development Pipeline Marketwired
11:42AM  Edited Transcript of AMRS earnings conference call or presentation 2-Nov-16 8:30pm GMT
Nov-02-16 05:47PM  Amyris reports 3Q loss
04:20PM  AMYRIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Amyris Reports Third Quarter 2016 Results GlobeNewswire
07:07AM  Q3 2016 Amyris Inc Earnings Release - After Market Close
Nov-01-16 05:05PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
02:17PM  Ahead of The Presidential Election, These Stocks Are Hitting New Highs
07:43AM  Biofuel Stock Earnings to Watch on Nov 2: REGI, PEIX, AMRS
Oct-31-16 03:42PM  Amyris to Present at Benchmark Micro Cap Discovery One-on-One Conference December 1, 2016 GlobeNewswire
08:30AM  BIOSSANCE to Launch in Sephora Stores GlobeNewswire
Oct-28-16 02:18PM  Amyris Enters Collaboration with Top 10 Pharmaceutical Company for Biosynthetic Drug Discovery GlobeNewswire
Oct-27-16 04:37PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
Oct-26-16 12:21PM  ETFs with exposure to Amyris, Inc. : October 26, 2016
09:48AM  Amyris Executes Definitive Collaboration Agreements with Leading Global Nutraceuticals Partner GlobeNewswire
Oct-25-16 08:30AM  Amyris to Announce Third Quarter Financial Results on Wednesday, November 2, 2016 GlobeNewswire
Oct-19-16 04:36PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
Oct-14-16 08:35AM  Amyris (AMRS) Worth Watching: Stock Rises 5.9% in Session
Oct-13-16 09:25AM  ETFs with exposure to Amyris, Inc. : October 13, 2016 +6.49%
08:30AM  Amyris Agrees to Collaboration Terms with Leading Global Food Ingredients and Nutraceuticals Partner GlobeNewswire
Oct-12-16 04:54PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement +20.31%
Oct-06-16 04:36PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Oct-04-16 08:30AM  Amyris and Autodesk Offer Powerful Open Source Tools for Genetic Design to Enable Rapid DNA Engineering GlobeNewswire
Oct-03-16 08:25AM  Amyris (AMRS) Shows Strength: Stock Moves 14.9% Higher
Sep-30-16 02:49PM  Amyris Inc (AMRS) Stock Gaining Big On Funding And Collaboration News at Insider Monkey +16.00%
10:44AM  Can The Uptrend Continue for Amyris (AMRS)?
08:30AM  Amyris Expands in Global Nutraceuticals Market with New Collaboration and Partner Funding of $30 Million GlobeNewswire
Sep-26-16 10:17AM  ETFs with exposure to Amyris, Inc. : September 26, 2016
Sep-16-16 08:30AM  Amyris to Present at Singular Research 11th Annual "Best of The Uncovereds" Conference September 22, 2016 GlobeNewswire
Sep-15-16 08:30AM  Amyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products GlobeNewswire
Sep-12-16 08:41AM  Is Amyris (AMRS) Stock a Solid Choice Right Now?
Sep-09-16 04:32PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
10:21AM  ETFs with exposure to Amyris, Inc. : September 9, 2016
08:30AM  Amyris in Partnership with Boticário Group Named Gold Winner by Cosmetics Design for Breakthrough Ingredient Neossance® Hemisqualane GlobeNewswire
Sep-07-16 08:30AM  Amyris to Present at Rodman & Renshaw 18th Annual Global Investment Conference on September 12, 2016 GlobeNewswire
Aug-24-16 08:30AM  Biossance Launches The Detoxifier A Breakthrough, Innovative Modeling Mask GlobeNewswire
Aug-23-16 11:18AM  ETFs with exposure to Amyris, Inc. : August 23, 2016
Aug-17-16 08:30AM  Biossance Launches The Illuminator A Clinically Proven, Weightless Eye Gel GlobeNewswire
Aug-12-16 02:07PM  ETFs with exposure to Amyris, Inc. : August 12, 2016
Aug-11-16 11:00AM  Amyris, Inc. :AMRS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-09-16 02:59PM  AMYRIS, INC. Files SEC form 10-Q, Quarterly Report
08:30AM  Enviva Partners, LP (EVA) Catches Eye: Stock Rises 5.3%
Aug-08-16 08:30AM  Amyris Wins Three-Year, Multi-Million-Dollar Contract from U.S. Department of Energy to Further Manufacturing of Cellulose-Derived Farnesene GlobeNewswire +5.26%
Aug-06-16 12:56PM  Edited Transcript of AMRS earnings conference call or presentation 4-Aug-16 8:30pm GMT
Aug-04-16 05:27PM  Amyris reports 2Q loss +11.76%
04:18PM  AMYRIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Amyris Reports Second Quarter 2016 Results GlobeNewswire
07:07AM  Q2 2016 Amyris Inc Earnings Release - After Market Close
Aug-03-16 09:05AM  Biofuel Stocks Earnings to Watch on Aug 4: REGI, AMRS, AMTX
08:30AM  Amyris Enters Partnership with Biogen to Develop Alternative Cell Lines Supporting Production of Therapeutics GlobeNewswire
Jul-19-16 08:30AM  American Refining Group Invests in Novvi to Accelerate Amyris Commercialization of Renewable Base Oil and Lubricant Platform GlobeNewswire
Jul-18-16 10:30AM  Amyris to Announce Second Quarter Financial Results on Thursday, August 4, 2016 GlobeNewswire
Jul-01-16 05:51PM  ETFs with exposure to Amyris, Inc. : July 1, 2016
Jun-30-16 09:09AM  Research Report Initiated on Select Specialty Chemicals Equities +9.76%
09:09AM  Research Report Initiated on Select Specialty Chemicals Equities Company Spotlight
Jun-29-16 04:38PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio +10.81%
08:25AM  Amyris (AMRS) Shows Strength: Stock Adds 7.1% in Session
07:35AM  [$$] Gormley's Take: Synthetic-Biology Companies Join Forces at The Wall Street Journal
07:30AM  Ginkgo Bioworks and Amyris Partner to Accelerate Commercialization of Bio-Based Products GlobeNewswire
Jun-28-16 12:00PM  Amyris Announces Long term, Multi-Million-Dollar Collaboration in Cosmetic Active Ingredients with Givaudan GlobeNewswire +5.71%
Jun-21-16 07:35PM  Weekly CEO Sells Highlights -10.00%
Jun-20-16 04:32PM  AMYRIS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
11:20AM  Why Intrexon Won't Commercialize Fuels by 2018 at Motley Fool
Jun-18-16 06:00PM  Demand for Aviation Biofuels Grows as Green Regulations Loom
Jun-14-16 08:30AM  Takasago and Amyris Begin Commercialization of Novel Fragrance Product Being Introduced at the 2016 World Perfumery Congress GlobeNewswire -8.77%
Jun-13-16 08:30AM  Amyris Fuels First Delivery of New Airbus A350-900 Airplane for Cathay Pacific as Part of Two-Year Biojet Agreement GlobeNewswire +9.62%
Jun-06-16 08:30AM  Amyris Announces Collaboration with Johnson & Johnson Innovation for Biosynthetic Drug Discovery GlobeNewswire +20.37%
Jun-02-16 09:00AM  Gen9 and Amyris Announce Supply Agreement for Synthetic DNA Business Wire
May-31-16 05:05PM  AMYRIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
May-27-16 08:30AM  Amyris to Participate in June 2016 Investor Conferences GlobeNewswire +5.36%
07:13AM  7 Stocks Under $10 to Trade for Big Profits
May-20-16 08:30AM  Amyris & CJ CheilJedang Corporation Creating Manufacturing and Sales Partnership GlobeNewswire
May-18-16 10:17PM  ETFs with exposure to Amyris, Inc. : May 19, 2016 -8.47%
04:28PM  AMYRIS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-17-16 01:53PM  Amyris, Inc. :AMRS-US: Earnings Analysis: Q1, 2016 By the Numbers
May-13-16 04:35PM  AMYRIS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events
May-11-16 02:42PM  Amyris to Participate in Upcoming Investor Conferences in May 2016 GlobeNewswire -16.05%
01:46AM  Edited Transcript of AMRS earnings conference call or presentation 10-May-16 8:30pm GMT
May-10-16 07:32PM  Amyris reports 1Q loss
05:08PM  AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
04:47PM  AMYRIS, INC. Files SEC form 10-Q, Quarterly Report
04:30PM  Amyris Inc Earnings Call scheduled for 4:30 pm ET today
04:15PM  Amyris First Quarter 2016 Results Deliver Strong Renewable Product Sales Growth and Continued Reduction in Operating Expenses GlobeNewswire
07:07AM  Q1 2016 Amyris Inc Earnings Release - After Market Close CCBN
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maxwell (Mauritius) Pte Ltd10% OwnerDec 08Sale0.81129,456104,31661,263,295Dec 09 06:09 AM
Maxwell (Mauritius) Pte Ltd10% OwnerDec 07Sale0.81156,167126,29261,392,751Dec 09 06:09 AM
Maxwell (Mauritius) Pte Ltd10% OwnerDec 06Sale0.81160,307129,40061,548,918Dec 07 06:04 AM
Maxwell (Mauritius) Pte Ltd10% OwnerDec 05Sale0.82418,243341,70561,709,225Dec 07 06:04 AM
Maxwell (Mauritius) Pte Ltd10% OwnerDec 02Sale0.84265,455222,77062,127,468Dec 05 06:58 AM
Maxwell (Mauritius) Pte Ltd10% OwnerDec 01Sale0.84290,841243,05662,392,923Dec 05 06:58 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 22Sale0.8077,28361,91962,683,764Nov 23 06:05 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 21Sale0.801008062,761,047Nov 23 06:05 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 17Sale0.8097,02677,66062,761,147Nov 18 06:08 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 16Sale0.81412,753333,09262,858,173Nov 18 06:08 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 15Sale0.82408,471333,76263,270,926Nov 16 06:06 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 14Sale0.81239,871193,50463,679,397Nov 16 06:06 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 11Sale0.805,6004,48063,919,268Nov 14 06:36 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 10Sale0.809,5937,68263,924,868Nov 14 06:36 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 09Sale0.81412,711333,59463,934,461Nov 14 06:36 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 08Sale0.82311,136254,04364,347,172Nov 09 06:32 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 07Sale0.8022,67518,14764,658,308Nov 09 06:32 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 04Sale0.81221,320178,47264,680,983Nov 07 06:20 AM
Maxwell (Mauritius) Pte Ltd10% OwnerNov 03Sale0.902,389,9132,146,38164,902,303Nov 07 06:20 AM
Maxwell (Mauritius) Pte Ltd10% OwnerOct 17Sale0.851,680,3451,425,60567,292,216Oct 18 07:27 AM
Maxwell (Mauritius) Pte Ltd10% OwnerOct 14Sale0.79619,655486,55368,972,561Oct 18 07:27 AM
Melo JohnPresident and CEOJun 14Sale1.04200,577208,6001,108,333Jun 16 07:31 PM